DrugDashboards

Fingolimod

Fingolimod · FINGOLIMOD HYDROCHLORIDE .5 mg/1 · Capsule · Oral · AvKARE

NDC 42291-0048-30 · 30 CAPSULE in 1 BOTTLE · ANDA · View full market →

The short version

18 companies supply this market — deep enough that no single failure threatens the supply.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$62.63per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$89.79per unitAvKare, LLC · Aug 15, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$3,099.30
Reported to Texas DSHS · 2026 annual filing · AvKare

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for fingolimod (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $2,055.06 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA208008
TE code
AB
Approval date
Jul 2, 2020
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Fingolimod (Capsule)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals Inc.FINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedFINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Apotex Corp.FINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedFINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
AvKAREFINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Biocon Pharma Inc.FINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.FINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
CivicaScript LLCFINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories IncFINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USAFINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Quallent Pharmaceuticals Health LLCFINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLCFINGOLIMOD .5 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.FINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals, Inc.FINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
XLCare Pharmaceuticals Inc.FINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Zydus Lifesciences LimitedFINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Zydus Pharmaceuticals USA Inc.FINGOLIMOD HYDROCHLORIDE .5 mg/1Jul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCFINGOLIMOD HYDROCHLORIDE .5 mg/1Aug 28, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fingolimod — NDC 42291-0048-30," retrieved September 3, 2026, https://drugdashboards.com/drug/42291004830.

Free to cite with attribution — see how the data is put together.